These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38438882)

  • 41. Rac-specific guanine nucleotide exchange factor DOCK1 is a critical regulator of HER2-mediated breast cancer metastasis.
    Laurin M; Huber J; Pelletier A; Houalla T; Park M; Fukui Y; Haibe-Kains B; Muller WJ; Côté JF
    Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7434-9. PubMed ID: 23592719
    [TBL] [Abstract][Full Text] [Related]  

  • 42. DNMT inhibitors and HDAC inhibitors regulate E-cadherin and Bcl-2 expression in endometrial carcinoma in vitro and in vivo.
    Yi TZ; Li J; Han X; Guo J; Qu Q; Guo L; Sun HD; Tan WH
    Chemotherapy; 2012; 58(1):19-29. PubMed ID: 22343305
    [TBL] [Abstract][Full Text] [Related]  

  • 43. miR-145-5p restrained cell growth, invasion, migration and tumorigenesis via modulating RHBDD1 in colorectal cancer via the EGFR-associated signaling pathway.
    Niu Y; Zhang J; Tong Y; Li J; Liu B
    Int J Biochem Cell Biol; 2019 Dec; 117():105641. PubMed ID: 31693935
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dock1 promotes the mesenchymal transition of glioma and is modulated by MiR-31.
    Zhang B; Li H; Yin C; Sun X; Zheng S; Zhang C; Shi L; Liu Y; Lu S
    Neuropathol Appl Neurobiol; 2017 Aug; 43(5):419-432. PubMed ID: 26946516
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells.
    Takai N; Desmond JC; Kumagai T; Gui D; Said JW; Whittaker S; Miyakawa I; Koeffler HP
    Clin Cancer Res; 2004 Feb; 10(3):1141-9. PubMed ID: 14871994
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [miR-497 inhibits the growth and metastasis of SGC-7901 human gastric cancer anoikis resistant cells via blocking Wnt/β-catenin signaling pathway].
    Yu L; Xu Y; Yang J; Gao L; Li H; Wang Z; Zhang Z; Ling Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Jul; 39(7):617-625. PubMed ID: 37403721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Total Flavonoids of Polygala fallax Hemsl Induce Apoptosis of Human Ectopic Endometrial Stromal Cells through PI3K/AKT/Bcl-2 Signaling Pathway.
    Zhong C; Ju G; Yang S; Zhao X; Chen J; Li N
    Gynecol Obstet Invest; 2023; 88(4):197-213. PubMed ID: 36934719
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overexpression of BMPER in Ovarian Cancer and the Mechanism by which It Promotes Malignant Biological Behavior in Tumor Cells.
    Xi Y; Nie X; Wang J; Gao L; Lin B
    Biomed Res Int; 2020; 2020():3607436. PubMed ID: 32309430
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Knockdown of lncRNA CCAT2 inhibits endometrial cancer cells growth and metastasis via sponging miR-216b.
    Xie P; Cao H; Li Y; Wang J; Cui Z
    Cancer Biomark; 2017 Dec; 21(1):123-133. PubMed ID: 29036788
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protective mechanism of artemisinin on rat bone marrow-derived mesenchymal stem cells against apoptosis induced by hydrogen peroxide via activation of c-Raf-Erk1/2-p90
    Fang J; Zhao X; Li S; Xing X; Wang H; Lazarovici P; Zheng W
    Stem Cell Res Ther; 2019 Oct; 10(1):312. PubMed ID: 31655619
    [TBL] [Abstract][Full Text] [Related]  

  • 51. LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway.
    Xing Y; Liu Y; Qi Z; Liu Z; Wang X; Zhang H
    Cell Mol Biol Lett; 2021 Nov; 26(1):49. PubMed ID: 34837962
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SULF2 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells through the ERK/AKT signaling pathway.
    Jiang T; Chen ZH; Chen Z; Tan D
    Braz J Med Biol Res; 2020; 53(2):e8901. PubMed ID: 32049100
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dual blockade of PI3K/AKT/mTOR (NVP-BEZ235) and Ras/Raf/MEK (AZD6244) pathways synergistically inhibit growth of primary endometrioid endometrial carcinoma cultures, whereas NVP-BEZ235 reduces tumor growth in the corresponding xenograft models.
    Schrauwen S; Depreeuw J; Coenegrachts L; Hermans E; Lambrechts D; Amant F
    Gynecol Oncol; 2015 Jul; 138(1):165-73. PubMed ID: 25933683
    [TBL] [Abstract][Full Text] [Related]  

  • 54. lncRNA RHPN1-AS1 promotes the progression of endometrial cancer through the activation of ERK/MAPK pathway.
    Zhang XJ; Qi GT; Zhang XM; Wang L; Li FF
    J Obstet Gynaecol Res; 2021 Feb; 47(2):533-543. PubMed ID: 33169491
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumor suppressor function of ezrin-radixin-moesin-binding phosphoprotein-50 through β-catenin/E-cadherin pathway in human hepatocellular cancer.
    Peng XL; Ji MY; Yang ZR; Song J; Dong WG
    World J Gastroenterol; 2013 Feb; 19(8):1306-13. PubMed ID: 23483729
    [TBL] [Abstract][Full Text] [Related]  

  • 56. KCC1 gene advances cell invasion ability by regulating ERK signaling pathway in endometrial cancer HEC-1B cell line.
    Shang C; Lu YM; Meng LR
    Int J Gynecol Cancer; 2011 Jul; 21(5):795-9. PubMed ID: 21666489
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PDCD6 cooperates with C-Raf to facilitate colorectal cancer progression via Raf/MEK/ERK activation.
    Wang X; Wu F; Wang H; Duan X; Huang R; Tuersuntuoheti A; Su L; Yan S; Zhao Y; Lu Y; Li K; Yao J; Luo Z; Guo L; Liu J; Chen X; Lu Y; Hu H; Li X; Bao M; Bi X; Du B; Miao S; Cai J; Wang L; Zhou H; Ying J; Song W; Zhao H
    J Exp Clin Cancer Res; 2020 Aug; 39(1):147. PubMed ID: 32746883
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.
    Jazirehi AR; Vega MI; Chatterjee D; Goodglick L; Bonavida B
    Cancer Res; 2004 Oct; 64(19):7117-26. PubMed ID: 15466208
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TRIM66 hastens the malignant progression of non-small cell lung cancer via modulating MMP9-mediated TGF-β/SMAD pathway.
    Chen W; Zhang Y; Fang Z; Qi W; Xu Y
    Cytokine; 2022 May; 153():155831. PubMed ID: 35301175
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CNR1 may reverse progesterone-resistance of endometrial cancer through the ERK pathway.
    Ding F; Qiu C; Li W; Liu Z; Kong D; Ma X; Jiang J
    Biochem Biophys Res Commun; 2021 Apr; 548():148-154. PubMed ID: 33640608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.